Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boston IVF operates one of the largest networks of fertility clinics in the United States. It has pioneered numerous advances in assisted reproductive technology since its founding in the mid–1980s. The company reports over 150,000 babies born through its programs since inception. Its research arm conducts clinical studies to improve embryo selection, sperm selection, diagnosis/treatment for PCOS/endometriosis/celiac disease-related infertility, and home-testing technologies. It maintains ongoing academic partnerships with Harvard Medical School and others[2][5].
Clinical results are consistently strong; it was responsible for several regional "firsts" such as New England's first successful IVF pregnancy and Massachusetts' first egg freezing birth[2][3][4].
The network offers access to clinical trials evaluating new reproductive technologies.
Pipeline breadth cannot be quantified as a traditional drug pipeline but includes multiple ongoing research initiatives.
No traditional drug development pipeline exists due to service-based business model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boston IVF.